Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings.
about
Discovery of estrogen receptor alpha target genes and response elements in breast tumor cellsChinese herbal medicine for menopausal symptomsChinese herbal medicine for menopausal symptomsAttenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.Natural products as aromatase inhibitorsRegulation of immune cell function and differentiation by the NKG2D receptorModulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancerEffect of long-term treatment with steroid hormones or tamoxifen on the progesterone receptor and androgen receptor in the endometrium of ovariectomized cynomolgus macaquesCooperating transcription factors mediate the function of estrogen receptorFolate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women.The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studiesMetabolomic profiling unravels DNA adducts in human breast that are formed from peroxidase mediated activation of estrogens to quinone methidesInterleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis.Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.The potential health effects of dietary phytoestrogensCASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies.Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.Case-control study of lifetime total physical activity and endometrial cancer riskN-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.Identification of collaboration patterns of dysfunctional pathways in breast cancer.Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathwayHormones after menopause?Risk factors of breast cancer: a systematic review and meta-analysis.Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro.Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy.An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivorsDo reproductive factors influence T, N, and M classes of ductal and lobular breast cancers? A nation-wide follow-up study.Nutrition and survival after the diagnosis of breast cancer: a review of the evidence.Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.Dietary iron intake and risk of endometrial cancer: a population-based case-control study in Shanghai, ChinaAssociation of overweight and obesity with breast cancer in India.Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 CellsDeclining second primary ovarian cancer after first primary breast cancer.ESR1 and EGF genetic variation in relation to breast cancer risk and survival.Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study.Long-term impact of preeclampsia on maternal endometrial cancer risk.Total and unopposed estrogen exposure across stages of the transition to menopause.
P2860
Q21184176-ADD85CB3-047E-4071-9A4D-C1495A6A6F7DQ24186027-9B4D964A-4058-4C4D-9C92-592688D2B82CQ24236416-827FBFD3-E58D-49A2-9B83-95507B2F26A2Q24562734-A24C3E37-CAFB-4ADE-BE25-B7A14BFB3353Q24620153-C4C35087-4EC1-4196-8B19-8B434A3E294DQ24635093-E77DC733-6197-4A50-9D0F-56F130297C6DQ24654971-22F816F7-F062-4067-8024-A80771FB6074Q24806253-EE3D1E0F-6B5D-411B-B577-27741C5EE801Q26996464-D9EA9AC9-327C-42C0-8973-73AF1D74B20DQ28193856-A594EB03-FC7B-4259-B236-CE389C410F38Q28384635-E67C6277-F912-4967-9AFC-12875A9D3ACAQ28533703-A269E7D4-8408-4E0B-BAD9-B87584306655Q33556402-A4E1C91C-6DFA-462F-83A6-F3D23FB5087AQ33579485-DC6BD7E3-E7C1-4C1A-98D3-0BA431EDCEDFQ33590672-5E530A16-CF14-4F49-9EF2-7B2900D6DB05Q33591382-5ACB02F1-6893-4CDE-990E-360BD6135224Q33676455-37FFA363-72C4-44FE-A2B4-3EFD44B01188Q33829218-3E76BB44-3939-499C-A251-49164BC54CCCQ33874365-16F1272C-0DAF-4C4F-9C12-243FBC3FB9A4Q33903471-608D1372-7C6A-4BC3-85E8-619B26D8F7E2Q33976415-430BB744-DFC5-45B0-9E8A-15F51171C1B7Q33991159-CE90EFB5-A885-488C-AB77-9695777A582FQ34028990-947AC9DF-2D96-4DE7-A723-47701607458CQ34119145-2E00645D-2BD2-4FFC-8F95-496782FED1DFQ34267973-B737B2D4-07D0-4CAC-AACB-FE51A6A8218BQ34346863-7B8B1111-DB8A-4121-A13D-B8AD15F08222Q34601427-AF55A996-C0C6-45F1-A6FE-20714B7C50DBQ34691744-EF5BFB2B-0C70-48DC-88A2-1997EF84B90DQ34712486-8927AD09-9F76-41C5-AB58-AD6C900BA099Q34755230-225ECED2-52A5-4890-B284-2A41D3A7BB55Q34767869-40494D1A-C26C-4DED-B186-C9508C0B4FA4Q34990550-BD986CE5-9CB2-41C7-A2EB-C08290C25D5CQ35027343-79EACE99-2A75-44B3-8247-45AF852EF097Q35686206-4995807C-1163-4F49-873D-AF537C0BCE9FQ35959401-229F80E7-1A37-4536-8089-B3C17988720BQ36615095-D5A5EB5E-0943-4090-A60A-36386B8A636EQ36643091-E4C8AF64-B86D-48F0-8F5D-EA59E67580D0Q36720348-0E6CDCEB-B992-4886-9812-D71B14B61F50Q37174960-856A41E9-ED68-4CE7-83F4-3E362D3B7A87Q37175273-3051779E-18A7-4B7D-B225-0ED6786D7062
P2860
Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Estrogens in the causation of ...... from epidemiological findings.
@ast
Estrogens in the causation of ...... from epidemiological findings.
@en
type
label
Estrogens in the causation of ...... from epidemiological findings.
@ast
Estrogens in the causation of ...... from epidemiological findings.
@en
prefLabel
Estrogens in the causation of ...... from epidemiological findings.
@ast
Estrogens in the causation of ...... from epidemiological findings.
@en
P1476
Estrogens in the causation of ...... from epidemiological findings.
@en
P2093
P304
P356
10.1016/S0960-0760(00)00113-8
P577
2000-11-01T00:00:00Z